138 related articles for article (PubMed ID: 32038795)
1. Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.
Bista SR; Lee SK; Thapa D; Kang MJ; Seo YM; Kim JH; Kim DH; Jahng Y; Kim JA; Jeong TC
Toxicol Res; 2008 Sep; 24(3):195-199. PubMed ID: 32038795
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
Chen L; Yang CS
Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Baek HW; Bae SK; Lee MG; Sohn YT
J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
Kwon MH; Lee CJ; Cho YY; Kang HE
J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
[TBL] [Abstract][Full Text] [Related]
6. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
Mizuno D; Tanaka E; Tanno K; Misawa S
Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC
Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
12. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.
Lee SK; Bista SR; Jeong H; Kim DH; Kang MJ; Jahng Y; Jeong TC
Arch Pharm Res; 2007 Dec; 30(12):1629-34. PubMed ID: 18254252
[TBL] [Abstract][Full Text] [Related]
13. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition.
Kim YG; Cho MK; Kwon JW; Kim SG; Chung SJ; Shim CK; Le Myung G
Biopharm Drug Dispos; 2002 Apr; 23(3):121-9. PubMed ID: 12173547
[TBL] [Abstract][Full Text] [Related]
14. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
[TBL] [Abstract][Full Text] [Related]
15. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
Shaik IH; Mehvar R
J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Ahn CY; Kim EJ; Lee I; Kwon JW; Kim WB; Kim SG; Lee MG
J Pharm Sci; 2003 Aug; 92(8):1604-13. PubMed ID: 12884247
[TBL] [Abstract][Full Text] [Related]
18. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E
Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Chung W; Kim EJ; Lee I; Kim SG; Lee MG; Kim SH
Life Sci; 2003 Jun; 73(3):253-63. PubMed ID: 12757833
[TBL] [Abstract][Full Text] [Related]
20. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
Mehvar R; Vuppugalla R
J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]